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Abstract  
BACKGROUND: Obesity is a multifactorial disease, associated with metabolic disorders and chronic low-grade 
inflammation. Procalcitonin (PCT) is well known as a biomarker of infection, and systemic inflammation. Recently, 
it has potential as a marker for chronic low-grade inflammation.  
AIM: This study aims to evaluate the role of serum PCT as an inflammatory biomarker in the diagnosis of obesity-
related low-grade inflammation. 
METHOD: In this case-control study, 50 obese and 35 normal weight children and adolescents aged 5–15 years 
were enrolled. Anthropometric parameters were measured in all subjects. Blood samples were collected for 
measurement of lipid profile, blood glucose, insulin, high sensitivity-CRP (Hs-CRP) and serum procalcitonin. 
Serum (PCT) levels were assessed using enzyme-linked immunosorbent assay. 
RESULTS: Obese participants had higher concentrations of serum PCT, total cholesterol, triglycerides, LDL-c, 
glucose and Hs-CRP than control group. On correlation analysis, procalcitonin had significant positive correlation 
with (BMI) z-score (P = 0.02), insulin (P = 0.00), insulin resistance (HOMA-IR) (P = 0.006), Hs-CRP (P = 0.02), 
total cholesterol (P = 0.04) and triglycerides (P = 0.00) in obese group. 
CONCLUSION: The increased serum procalcitonin concentrations were closely related to measures of adiposity, 
Hs-CRP and insulin resistance, suggesting that PCT may be an excellent biomarker for obesity-related chronic 
low-grade inflammation in children and adolescents. 
 
 
 
 
 
 
Introduction 
 
Childhood obesity is one of the most 
important public health problems with increasing 
prevalence worldwide in this century. Childhood 
obesity is more prevalent in low and middle-income 
countries, especially in urban areas. In 2016, the 
number of overweight children below 5 years old, 
worldwide, is approximately 41 million. About fifty 
per cent of overweight children below five years are 
from Asia, and twenty-five per cent are from Africa 
[1]. The aetiology of obesity is complicated, a range 
of factors are suggested to play a role, including 
factors related to the lifestyle preferences, 
genetic, neuroendocrine, metabolic, immunologic, 
environmental, social and cultural factors [2] 
Obesity is associated with the chronic low-grade 
inflammatory reaction. This type of inflammation can 
be differentiated from normal inflammation by the 
absence of ordinary signs of inflammatory 
reactions. However, it shares the same diseases 
caused by typical inflammatory mediators and 
signalling pathway [2] [3]. 
Procalcitonin is the precursor to the 
hormone calcitonin, which is produced by all tissues 
throughout the body [4]. Production of procalcitonin 
occurs mainly in response to bacterial toxins and 
some inflammatory mediators. On the contrary, 
t h e  downregulation of procalcitonin occurs in the 
course of viral infection. The definite physiological 
role of procalcitonin is not yet completely 
recognised [5]. Procalcitonin level can be detected 
in serum after about 3-6 hours after the onset of 
inflammation and stay raised for 12-36 hours after 
recovery [6]. 
Procalcitonin has been identified as a 
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marker of infections and significant systemic 
inflammatory states [7]. Previously, research proved 
the ability of adipose tissue to express and produce 
procalcitonin [8]. This provides evidence for the 
relation between inflammation and obesity, 
considering procalcitonin a potential marker for it [9]. 
The objective of this study is to 
investigate the role of procalcitonin as a marker 
of inflammation in childhood obesity and its 
relationship with markers of obesity and other 
metabolic indices. 
 
 
Subjects and Method 
 
The present study included fifty children with 
simple obesity. Their age ranged from 5 to 15 years, 
with mean age 10.1 ± 2.5 years and 35 non-obese 
healthy children were enrolled as a control group 
with a mean age of 9.3 ± 2.1 years. Children with a 
diagnosis of obesity were recruited from the child 
health clinic in Medical and Scientific Centre of 
Excellence, National Research Centre. Obesity is 
defined as BMI greater than the 95th percentile on 
the growth charts from the National Center of 
Health and Statistics (NCHS). Exclusion criteria 
included genetic and endocrinal causes of obesity, 
children with chronic debilitating diseases, mental 
retardation, and use of drugs that affect blood 
pressure, lipid profile, or glucose level. Informed 
consents were obtained from the parents of the 
children studied, and the study was approved by 
the medical ethical committee of the National 
Research Centre, Cairo, Egypt. 
A full history was taken from all 
participants. Also, thorough clinical examination 
and anthropometric measurements were done. A 
calibrated Seca scale was used to weigh children 
to the nearest 0.1 kg (Seca, Hamburg, Germany), 
whereas a Seca 225 stadiometer was used to 
measure height to the nearest 0.1 cm, with the 
children dressed in minimal clothes and without 
shoes [10]. Each measurement was taken as the 
mean of three consecutive readings following the 
recommendations of the International Biological 
Program [11]. BMI for age was recorded according to 
WHO standards using AnthroPlus software for 
personal computers [12]. Weight for age, height for age 
and BMI Z-score were determined using the new WHO 
reference [13]. Measurements of waist circumference, 
hip circumference, W/H ratio and blood pressure were 
done. 
Morning venous blood sample (3 ml) was 
withdrawn after 12 hours overnight fasting into a plain 
tube and left to clot. The serum was separated by 
centrifugation for 10 minutes at 5000 rpm and stored 
at-20 until assays done. Fasting serum glucose, 
fasting serum insulin, cholesterol, triglycerides (TG), 
high-density lipoprotein cholesterol (HDL-c) were 
measured by calorimetric method. 
Serum LDL-C levels were calculated using 
the Friedewald formula [LDL-C=Total cholesterol-
HDL-C- (Triglyceride/5)] [14]. 
C-reactive protein was determined using a 
latex agglutination technique [15]. Procalcitonin 
(Human) ELISA Kit was used for the quantitative 
measurement of human Procalcitonin in serum 
(Bioassay Technology Laboratory). The detection 
range of this kit was 5 pg/ml - 20000 pg/ml [16]. 
Data entry was carried out in excel sheet, and 
statistical analysis was done using SPSS software 
program version 20.0, the measurement data 
presented as a mean ± standard deviation. A t-test 
was done for comparison between two means. Simple 
linear correlation (Pearson correlation) for quantitative 
data was also done. P value was considered 
statistically significant when P was <0.05 and 
considered statistically highly significant when its 
value was < 0.001. 
 
 
Results 
 
Comparisons between mean ± SD values of 
studied parameters in obese and non-obese groups 
are shown in (Table 1 & 2). The study comprised fifty 
obese children (34 females and 16 males) with 
mean age 10.1 ± 2.5 years and 35 non-obese 
healthy children (18 females and 17 males) with mean 
age 9.3 ± 2.1 years, considered as control group, 
there were highly significant statistical differences 
between them as regard weight z-score, body 
mass index z-score, waist circumference, hip 
circumference, mid-arm circumference, fasting blood 
glucose, cholesterol, triglycerides, LDL, hs-CRP, and 
PCT. Also significant statistical differences between 
them as regard waist/hip ratio, insulin and HOMA-IR. 
The comparison between males and females as 
regards the mean PCT level revealed a non-
significant difference. 
Table 1: Characteristics of the study group 
Characteristics Obese 
N = 50 
Non Obese 
N = 35 
t p- value 
 Mean ± SD Mean±SD   
Age (years) 10.1 ± 2.5 9.3 ± 2.1 1.34 0.185 
Weight z-score 2.54 ± 1.07 0.96 ± 0.6 7.02 0.000** 
Height z-score -0.91 ± 0.79 -0.70 ± 0.9 0.79 0.4 
Z score-BMI 2.77 ± 0.6 1.7 ± 0.46 7.72 0.00** 
Waist circumference 100.7 ± 18.6 69.9 ± 9.8 7.23 0.000** 
Hip circumference 109.6 ± 17.8 79.4 ± 14.8 7.84 0.000** 
Waist/hip ratio (WHR) 0.96 ± 0.34 0.79 ± 0.41 2.74 0.04* 
Mid arm circumference (MAC) 33.4 ± 7.5 18.4 ± 5.4 9.75 0.000** 
SD: standard deviation, BMI: body mass index. * if p≤0.05, then the relation is statistically 
significant. ** if p≤0.001, then the relation is statistically highly significant. 
 
 
 El Kassas et al. Role of Procalcitonin As an Inflammatory Marker in a Sample of Egyptian Children 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Aug 20; 6(8):1349-1353.                                                                                                                                                  1351 
 
Table 2: Laboratory characteristics of the study group 
Characteristics Obese  
N = 50 
Non Obese  
N = 35 
t P- value 
 Mean ± SD Mean ± SD   
Insulin (mg/dl) 14.80 ± 4.5 9.50 ± 3.4 2.208 0.03* 
HOMA IR 3.87 ± 1.12 1.75 ± 0.93 3.243 0.00** 
FBG (mg/dl) 97.43 ± 15.5 72.64 ± 11.78 7.323 0.00** 
Cholesterol (mg/dl) 201.46 ± 39.84 89.81 ± 17.5 13.244 0.00** 
LDL (mg/dl) 119.8 ± 40.63 40.74 ± 9.53 12.069 0.00** 
HDL (mg/dl) 47.39 ± 10.3 61.47 ± 9.4 -3.864 0.00** 
TG (mg/dl) 121.74 ± 39.76 79.89 ± 19.74 3.644 0.00** 
Hs-CRP (mg/dl) 4.89 ± 2.2 1.02 ± 0.66 9.462 0.00** 
Procalcitonin (pg/ml) 388.68 ± 114.19 122.38 + 21.48 12.815 0.000** 
Hs-CRP: high sensitive C-reactive protein, FBG: fasting blood glucose; HOMA-IR: 
homeostasis model assessment of insulin resistance, LDL-C: low-density lipoprotein 
cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides. * if P ≤ 0.05, 
then the relation is statistically significant. ** if P ≤ 0.001, then the relation is statistically 
highly significant. 
 
Results of the correlations of the various 
parameters with procalcitonin in obese children 
showed that there was strong significant positive 
association between procalcitonin and Weight z-
score (r = 0.34; P = 0.01), BMI z-score (r = 0.31; P 
= 0.02) as shown in Fig. 1, insulin (r = 0.4; P = 
0.00), HOMA-IR (r = 0.37; P = 0.006) as shown in 
Fig. 2, Hs-CRP (P = 0.02), cholesterol (r = 0.3; P = 
0.04), and triglycerides (r = 0.41; P = 0.00) as shown 
in Fig. 3, while there were no significant correlations 
with age, height z-score, waist circumference, fasting 
blood glucose, LDL-cholesterol and HDL-cholesterol. 
 
Figure 1: Correlation between procalcitonin and BMI z-score 
 
 
 
Discussion 
 
The research for the pathogenesis of obesity 
during the last decades had shown a strong link 
between excessive nutrient intake and activating the 
innate immune response in many organs relevant to 
energy homeostasis [17] [18]. 
Strong correlations were reported between 
plasma concentrations of procalcitonin and the 
degree of inflammatory responses [19]. Procalcitonin 
is indicated mainly for diagnosing bacterial infections 
that precipitate systemic inflammatory responses. It 
shows high degrees of stability, with prolonged half-
life and easy method of determination, making it 
perfect for clinical application [20].  
 
Figure 2: Correlation between procalcitonin and HOMA-IR 
 
Moreover, it was suggested that plasma PCT 
could be a marker of inflammation without the 
manifestations of systemic infection or sepsis [21] [22]. 
Adipose tissues have been considered as an 
endocrine organ, expressing calcitonin mRNA [23]. 
Also, it was found that adipocyte excretion of 
procalcitonin in vitro was triggered by activated 
macrophages [24], and the existence of those 
macrophages in adipose tissue has been reported to 
be associated proportionately to the extent of obesity 
[25]. 
 
Figure 3: Correlation between procalcitonin and triglycerides 
 
The objective of this study is to 
investigate procalcitonin serum concentrations in a 
group of obese children in comparison with non-
obese children, and studying the correlation of 
procalcitonin with some metabolic indices and 
anthropometric measurements. 
The study findings showed a significant 
difference in procalcitonin serum concentration 
between obese and non-obese children and a 
significant positive association between procalcitonin 
and BMI z-score. In accordance, it was reported 
that, in obesity-related inflammation, there is a 
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proportional association between the amount of 
adipose tissue and the increased generation of 
inflammatory mediators [26]. Also, our results showed 
a positive correlation between procalcitonin and 
weight z-score, insulin and HOMA-IR. 
In agreement with our results, Abbasi and 
colleagues who conducted a cross-sectional study on a 
general population, reported a higher procalcitonin 
level in more obese subjects, our results were also 
matching regarding the association of plasma 
procalcitonin with insulin resistance [9]. A recent 
study in Egypt, investigated procalcitonin level in type 
2 diabetic patients and assessed its relation with 
obesity, the authors reported, significantly higher 
concentrations of procalcitonin, hs-CRP and HOMA-
IR in obese compared to non-obese patients [27]. 
Moreover, Boursier et al., [28] found high plasma 
procalcitonin levels of their subjects associated with 
the degree of obesity, but in contrast to our results, they 
found no association between procalcitonin and insulin 
resistance. However, it is well known that increased 
adiposity is one of the major predisposing factors in 
developing insulin resistance [29]. Moreover, several 
studies suggest that inflammatory reactions that 
occur as a result of obesity may be implicated in 
the generation of insulin resistance, deficient 
insulin production, and disrupted energy 
homeostasis [30]. In accordance, Chen and his 
colleagues found a significant positive correlation 
between inflammatory markers and insulin 
resistance [31]. Also, Indulekha and his colleagues 
suggested that the relation between inflammatory 
reactions and insulin resistance indicates a 
continued cytokine- generated acute phase reactions 
[32]. 
On the other hand, the group of obese 
children in this study presented a state of disturbed 
lipid profile, and there was a significant correlation 
between procalcitonin, total cholesterol and 
triglycerides levels. These findings are supported by 
the accumulating evidence that reveals the 
association of systemic-obesity-related inflammation 
with the risk of developing cardiovascular disease 
(CVD). Hence, several obesity-associated factors 
including dyslipidemia are involved in CVD risk. In 
this regard, pro-inflammatory cytokines, are 
suggested to affect the liver, leading to alterations in 
the release of lipoproteins and inflammatory 
mediators [33] [34]. Particularly, they cause an 
elevation of very low-density lipoprotein, 
apolipoprotein B, and triglyceride levels [35]. C-
reactive protein is a highly sensitive inflammatory 
marker, it is produced from the liver, and its production 
is controlled mostly by IL-6 [36]. Previous research has 
evidenced that concentrations of C-reactive protein 
have a positive relationship with BMI in healthy 
subjects [37]. 
Moreover, several studies have shown that 
CRP is associated with most obesity markers [38]. 
Our results showed significantly higher hs-CRP levels 
in obese children compared to non- obese. In 
accordance, Ahmed et al., [39], evaluated the role of 
some inflammatory mediators and adipokines in 
obese Egyptian children; they reported that the mean 
level of CRP was significantly elevated in obese 
children compared with controls. 
In conclusion, the findings of this study 
revealed the significance of serum procalcitonin as a 
marker of obesity-related low-grade inflammation in 
obese children. 
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